Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROBIN: Bendamustine in Indolent NHL
NCT01289223Phase 3Terminated
- Sponsor
- Mundipharma
- Start
- Feb 2011
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of bendamustine in B-cell non-Hodgkin lymphoma, sponsored by Mundipharma. Started Feb 2011; status: terminated.
02
Drugs
bendamustine
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT01289223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01289223.